Context. “Compound 24” (Amgen) is a kinesin-like protein 18A (KIF18A) inhibitor being developed for a subset of cancers with chromosomally unstable tumor cells. Their first-in-class, oral clinical candidate, AMG…
Drug Hunter
Drug Hunter
Context. “Compound 24” (Amgen) is a kinesin-like protein 18A (KIF18A) inhibitor being developed for a subset of cancers with chromosomally unstable tumor cells. Their first-in-class, oral clinical candidate, AMG…